Recombinant deoxyribonucleoside kinase from Drosophila melanogaster can improve gemcitabine based combined gene/chemotherapy for targeting cancer cells. Biomol Biomed [Internet]. 2019 Nov. 8 [cited 2025 Jul. 6];19(4):342-9. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/4136